000 01299 a2200373 4500
005 20250516221416.0
264 0 _c20150605
008 201506s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.2101
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGiesen, Eva
245 0 0 _aNY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma.
_h[electronic resource]
260 _bOncotarget
_cJul 2014
300 _a5209-17 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntigens, Neoplasm
_xanalysis
650 0 4 _aCarcinoma, Renal Cell
_ximmunology
650 0 4 _aCohort Studies
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aKidney Neoplasms
_ximmunology
650 0 4 _aMembrane Proteins
_xanalysis
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNeoplasm Metastasis
650 0 4 _aTissue Array Analysis
700 1 _aJilaveanu, Lucia B
700 1 _aParisi, Fabio
700 1 _aKluger, Yuval
700 1 _aCamp, Robert L
700 1 _aKluger, Harriet M
773 0 _tOncotarget
_gvol. 5
_gno. 14
_gp. 5209-17
856 4 0 _uhttps://doi.org/10.18632/oncotarget.2101
_zAvailable from publisher's website
999 _c23958534
_d23958534